Cover Image

Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature

Abstract Objectives To describe clinical characteristics, laboratory tests, radiological data and outcome of pediatric cases with SARS-CoV-2 infection complicated by neurological involvement. Study design A computerized search was conducted using PubMed. An article was considered eligible if it repo...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. Siracusa (Author), A. Cascio (Author), S. Giordano (Author), A. A. Medaglia (Author), G. A. Restivo (Author), I. Pirrone (Author), G. F. Saia (Author), F. Collura (Author), C. Colomba (Author)
Format:	Book
Published:	BMC, 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neurological consequences of SARS-CoV-2 infections in the pediatric population
by: Manon Casabianca, et al.
Published: (2023)

Neurological Symptoms of SARS-CoV-2 Infection in Pediatric Patients
by: Donghwa Yang, et al.
Published: (2022)

Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature
by: Alice Annalisa Medaglia, et al.
Published: (2021)

Pediatric neurology and telehealth before and during SARS-CoV-2 pandemic
by: Beata Golebiowska, et al.
Published: (2021)

Acute Neurological Presentation in Children With SARS-CoV-2 Infection
by: Antonella Riva, et al.
Published: (2022)

Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations
by: Omkar Indari, et al.
Published: (2021)

A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection
by: Lauren O'Loughlin, et al.
Published: (2021)

Clinical characteristics, treatment and prognosis of children with SARS-CoV-2 infection complicated with severe neurological dysfunctions in Foshan, China
by: Xiaoqian Chen, et al.
Published: (2024)

SARS-CoV-2 vaccinations complicated by transverse myelitis
by: Josef Finsterer
Published: (2022)

Risk factors associated with SARS-CoV-2 pneumonia in the pediatric population
by: Moisés Moreno-Noguez, et al.
Published: (2021)

Erythrodermic Psoriasis Following SARS-CoV-2 Infection
by: F.Z. Agharbi, et al.
Published: (2024)

Assessing the risks of SARS-CoV-2 in wildlife
by: R. J. Delahay, et al.
Published: (2021)

The importance of SARS-CoV-2 testing in pediatric population
by: Rodica Demenciuc, et al.
Published: (2022)

Rhabdomyolysis in Pediatric Patients with SARS-CoV-2 Infection
by: Ping-Sheng Wu, et al.
Published: (2022)

Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms
by: Yoshitaka Kase, et al.
Published: (2021)

Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?
by: Ayssa Teles Abrao Trad, et al.
Published: (2020)

Cell culture models for SARS-CoV-2 infectivity and systemic complications
by: Khanit Sa-ngiamsuntorn, et al.
Published: (2022)

SARS-CoV-2-Triggered Hemophagocytic Lymphohistiocytosis with Complications of Posterior Reversible Encephalopathy Syndrome
by: Ross M. Perry, et al.
Published: (2024)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021)

SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing
by: Ahmed N. Ansari, MD, et al.
Published: (2024)

SARS-CoV-2: The Second Wave in Europe
by: Fokas, Athanassios S, et al.
Published: (2021)

Understanding Laboratory Testing for SARS-CoV-2
by: Ritu Cheema, et al.
Published: (2021)

Critically Ill Pediatric Patient and SARS-CoV-2 Infection
by: Jozef Klučka, et al.
Published: (2022)

A Characterization of Neurology Consults for Inpatients with SARS-CoV-2 Infection Compared to Other Respiratory Viruses
by: Brian E. Emmert, et al.
Published: (2023)

SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome
by: Vito Fiore, et al.
Published: (2021)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
by: Liu T, et al.
Published: (2021)

The rationale for methylene blue utility against SARS-CoV-2 infection complications
by: Gilberto L. Pardo Andreu
Published: (2021)

Prevalence of SARS-CoV-2 in newborns born to SARS-CoV-2-positive mothers at 2 weeks of life
by: Sophia Jan, et al.
Published: (2024)

The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections
by: Abdulrahim A. Sajini, et al.
Published: (2020)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021)

[Artículo traducido] Psoriasis eritrodérmica tras infección por SARS-CoV-2
by: F.Z. Agharbi, et al.
Published: (2024)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
by: G. Kanimozhi, et al.
Published: (2021)

Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease
by: Valeria Dipasquale, et al.
Published: (2021)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

Neurological Manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 Omicron variant in Shanghai, China
by: Xiaolei Shen, et al.
Published: (2023)

Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature
by: Sara Eslait-Olaciregui, et al.
Published: (2023)